54A Stock Overview
Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Cann Global Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.013 |
| 52 Week High | AU$0.25 |
| 52 Week Low | AU$0.011 |
| Beta | 1.27 |
| 1 Month Change | -46.00% |
| 3 Month Change | 8.00% |
| 1 Year Change | -86.50% |
| 3 Year Change | -97.43% |
| 5 Year Change | -89.20% |
| Change since IPO | -99.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| 54A | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -3.6% | 0.1% | -1.9% |
| 1Y | -86.5% | -29.2% | 1.1% |
Return vs Industry: 54A underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: 54A underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| 54A volatility | |
|---|---|
| 54A Average Weekly Movement | 35.3% |
| Pharmaceuticals Industry Average Movement | 7.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 54A's share price has been volatile over the past 3 months.
Volatility Over Time: 54A's weekly volatility has decreased from 192% to 35% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | Sholom Feldman | www.canngloballimited.com |
Cann Global Limited operates in medicinal cannabis and hemp food industries in Australia and internationally. The company operates through Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation segments. It grows and cultivates hemp and medical cannabis products; and provides plant-based food and skincare products.
Cann Global Limited Fundamentals Summary
| 54A fundamental statistics | |
|---|---|
| Market cap | €5.23m |
| Earnings (TTM) | -€3.34m |
| Revenue (TTM) | €659.78k |
7.9x
P/S Ratio-1.6x
P/E RatioIs 54A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 54A income statement (TTM) | |
|---|---|
| Revenue | AU$980.09k |
| Cost of Revenue | AU$752.05k |
| Gross Profit | AU$228.03k |
| Other Expenses | AU$5.19m |
| Earnings | -AU$4.97m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Mar 07, 2022
| Earnings per share (EPS) | -0.019 |
| Gross Margin | 23.27% |
| Net Profit Margin | -506.61% |
| Debt/Equity Ratio | 0.7% |
How did 54A perform over the long term?
See historical performance and comparison